INGREDION INCORPORATED (INGR): what the price assumes

boothcheck covers INGREDION INCORPORATED (INGR) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/INGR

Headline

FieldValue
TickerINGR
CompanyINGREDION INCORPORATED
Current price$102.55/sh
CompositionTexture & Healthful Solutions (T&HS) 33% / Food & Industrial Ingredients - LATAM (F&II-LATAM) 32% / Food & Industrial Ingredients - U.S./Canada (F&II-U.S./Canada) 28% / All Other 6%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)4.1%
Operating margin today13.1%
Margin compression (value-band)-9.0pp
Multiple paid8x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7.3% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.50σ
cohort percentile (of 68 peers)2
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.81x5justifies
Earnings0.91x5justifies
Relative0.49x5justifies
Growth1.23x4expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=19)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$70.851.45xyesFCF base $0.4B, growth -2% (input: historical growth), terminal g 0.5%, WACC 8.0%, 5yr projection
DCF Exit MultipleGrowth$100.371.02xyesExit EV/EBITDA: 5.5x / 7.5x / 9.5x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$190.790.54xyesP/E 17.1x (blended: static sector reference 22x + trailing (TTM) 10x), scenarios: 14.4x / 17.1x / 19.8x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$115.180.89xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$113.850.90xyesBV/sh $68.83, ROE (TTM) 15.3%, ke 9.3%
Two-Stage Excess ReturnAsset$144.650.71xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$60.771.69xyesRev $7.2B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.8x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$207.420.49xyesEPS $10.38, growth 20% (input: historical EPS growth), PEG=0.49 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$118.550.87xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.92B × (1−26%) / WACC 8.0% → EPV (no growth)
Residual IncomeAsset$148.010.69xyesBV $68.83 + 5yr PV of (ROE (TTM) 15.3% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$126.790.81xyes√(22.5 × EPS $10.38 × BVPS $68.83) — Graham's conservative floor
EV/EBITDA RelativeRelative$204.080.50xyesEBITDA $1.00B × sector EV/EBITDA 14.0x
FCF YieldEarnings$61.611.66xyesFCF $449.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$55.361.85xyesSBC-adj FCF $0.41B (FCF $0.45B − SBC $0.04B) capitalized at Kₑ
Ben Graham FormulaEarnings$334.930.31xyesEPS $10.38 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$24.254.23xyesBV $68.83 × (ROIC 2.8% / WACC 8.0%)
P/Sales SectorRelative$224.940.46xyesRevenue $7.20B × sector P/S 2.0x
PEG Fair ValueRelative$311.130.33xyesEPS $10.38 × (PEG 1.5 × growth 20.0% (input: historical EPS growth)) → PE 30.0x
Earnings YieldEarnings$112.220.91xyesEPS $10.38 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$911.0m
Net debt / NOPAT (after-tax)1.30x
Net debt / operating income (pre-tax)0.97x
Share count CAGR (buyback)-1.4%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Ingredion is a mature, established business, and reading it correctly means separating the steady, high-value part from the commodity part, because the market tends to price the whole company on the commodity. The Texture and Healthful Solutions segment is the prize: it sells specialty texturizers, plant-based proteins, and clean-label ingredients that food companies design into recipes and do not easily switch out, which gives it pricing power and margins well above the rest of the company. Management has been steering capital toward it, including incremental specialty capacity investments, precisely because that is where durable value sits. For a mature company, growth comes from mix, not from doing more volume, and Ingredion's mix is shifting toward the part of the business that earns its keep.

The core delivered a record before the recent stumble, which matters for what the normalized earnings power actually is. Ingredion produced record full-year results in 2025, with adjusted EPS in the range of $11.10 to $11.30, driven by Texture and Healthful Solutions strength and solid results in its Latin American food and industrial business. The Latin American operation, despite softer sweetener demand, managed pricing effectively against changing corn costs and currency swings, which is the kind of operational agility that comes from decades in the region. A company that can hold pricing through corn-cost and currency volatility has a more resilient model than its thin headline margin suggests.

The valuation is where a mature, cash-generative business gets interesting. The stock trades around 7 times operating income, a multiple so low it sits below what even a steady decline in profit would warrant, and every family of valuation method supports the price, with peer multiples reading it as distinctly cheap. The balance sheet is conservative: net debt is under one year's operating income, and the share count has been falling on buybacks. A mature ingredients company with a growing specialty segment, modest leverage, and a record-earnings base, priced at a single-digit operating multiple, is the kind of name where even flat earnings and continued buybacks compound per-share value. The bull case is that the market is pricing the recent earnings dip as permanent when the specialty engine and the cash generation argue otherwise.

Bear Case

The external variable with the most leverage on Ingredion is input cost and trade policy, and both turned against it at once. The company's largest raw material is corn, and a meaningful share of its product is commodity sweeteners and starches where it has limited ability to pass through cost spikes quickly. When corn prices move or currencies swing, particularly the Latin American currencies where a large part of the business sits, the margin on the commodity segments compresses before pricing can catch up. Layered on top is tariff policy: management explicitly tied its lowered 2026 guidance to tariff levels in effect as of late April 2026, a reminder that a global ingredients supplier with cross-border flows is directly exposed to trade barriers it does not control. The current price does not fully reflect how much these external levers can move the earnings, because it is anchored to a record 2025 that the 2026 guidance already walks back.

The downgrade is the bear's evidence, and it is recent and specific. Ingredion cut full-year 2026 guidance to adjusted EPS of $10.45 to $11.15 from the record 2025 level, and Q1 2026 EPS fell to $2.34 adjusted from $2.97 a year earlier. The company expects reported operating income down high single digits for the year. Part of the miss was self-inflicted: operational disruptions at the critical Argo facility ran costs significantly above forecast. A single plant problem flowing through to a guidance cut shows how concentrated the manufacturing footprint is, and how little buffer a 13% operating margin leaves when something goes wrong.

The structural ceiling is the commodity nature of much of the portfolio. The Food and Industrial Ingredients segments compete in markets where the products are largely interchangeable and demand for sweeteners is, if anything, in secular decline as consumers cut sugar and high-fructose corn syrup. The specialty segment is the answer, but it is not yet large enough to make the whole company a specialty business, so Ingredion remains substantially a corn processor exposed to crop economics. The valuation is cheap, and the balance sheet is sound, so this is not a solvency bear. The bear case is that the cheapness is the market correctly pricing a business whose earnings just stepped down, whose largest inputs and end markets move against it, and whose recovery depends on macro and trade conditions improving rather than on anything the company can control.

Valuation

The price is set for decline, not growth. At about $98 (June 27, 2026) Ingredion trades near 7 times operating income, a multiple so low that the price sits below what even a steady mid-single-digit drop in operating profit would warrant. That is the market pricing the recent earnings step-down as a trend: 2026 guidance already calls for reported operating income down high single digits, and the stock multiple is discounting more of the same. The reference point is the company's own record 2025, so the price is essentially betting that the record was the peak.

The methods we use to triangulate uniformly support the price, several of them reading it as outright cheap. When every family agrees a profitable, cash-generative ingredients company is inexpensive, the question is whether the cheapness is opportunity or a correct read on deteriorating fundamentals. The cleanest interpretation is that the market has marked the stock down to reflect the lowered guidance and the macro headwinds, leaving little premium for the specialty segment's quality. Against its consumer-staples and food-ingredients peers, Ingredion sits at a clear discount, which fits a business the market views as more commodity than specialty.

Solvency is a source of support rather than concern. Net debt is about $911 million, under one year's operating income, and the share count has been declining on buybacks, though interest expense is not separately broken out in the latest filings so a precise coverage figure is not available. The balance sheet comfortably carries the business through a weak earnings year and funds the continued buyback. What bounds the downside is therefore the value of the franchise even at the reduced earnings level, plus the low multiple, rather than any balance-sheet fragility. The buyer at this price is paying a deep-value multiple for a mature ingredients company with a quality specialty segment, accepting that the near-term earnings are pressured by corn costs, tariffs, currency, and a plant disruption, in exchange for a price that already assumes the pressure persists.

Catalysts

The recent results mark a turn from record to retreat. Ingredion delivered record full-year 2025 results with adjusted EPS in the $11.10 to $11.30 range, led by Texture and Healthful Solutions and solid Latin American food and industrial performance. Then the trajectory reversed: first-quarter 2026 reported and adjusted EPS came in at $2.22 and $2.34, down from $3.00 and $2.97 a year earlier, and the company cut full-year 2026 guidance to reported EPS of $9.60 to $10.30 and adjusted EPS of $10.45 to $11.15.

The drivers behind the downgrade are the catalysts to track. Management cited tariff levels in effect as of late April 2026, persistent macroeconomic headwinds in North America and Latin America, and significantly higher-than-forecast costs from operational disruptions at the critical Argo facility. It also expects net sales flat to up low single digits, with volume growth partly offset by weaker price mix. The events to watch are the resolution of the Argo facility issues, the path of corn costs and the Latin American currencies, any change in tariff policy, and the continued momentum of the Texture and Healthful Solutions segment, because together they determine whether 2026 is a one-year dip or the start of a longer reset in earnings.

Peer Cohorts (Per Segment, With Filing Citations)

Texture & Healthful Solutions (T&HS) (reported)

F&II-LATAM / F&II-U.S./Canada (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Ingredion 2026 guidance, 8-K · Ingredion 2026 commentary · Ingredion corporate announcements · Ingredion FY2025 results, 8-K · Ingredion 2026 guidance · Ingredion Q1 2026 results, 8-K

View the full interactive INGR report on boothcheck